Therapeutic Glycoprotein Development and Analysis

Custom synthesis of structurally defined glycans is performed with precise composition control. These glycans are widely used in glycomics research, assay development, and therapeutic studies.

Integrated platforms support therapeutic glycoprotein development across multiple stages. Services cover glycoprotein design, protein production, and advanced glycosylation characterization.

Antibody glycoengineering strategies enable precise modulation of Fc and Fab glycosylation. Such modifications enhance antibody efficacy, stability, and functional performance.

High-specificity anti-glycan antibodies are generated against defined carbohydrate epitopes. These antibodies facilitate glycan detection, validation, and functional investigations.

Cell line glycoengineering enables controlled and consistent protein glycosylation profiles. Optimized expression systems support recombinant glycoprotein production.

Comprehensive analysis reveals glycan composition and site-specific glycosylation patterns. The resulting data supports structure–function studies and development decisions.

Advanced analytical approaches characterize glycosaminoglycan structural features. Analyses address composition, sulfation patterns, and chain heterogeneity.

Detailed structural analysis elucidates the architecture of complex polysaccharides. This includes linkage determination, monosaccharide composition, and molecular organization.

Quantitative profiling measures key biomass components across diverse biological materials. Results support compositional analysis and bioprocess optimization.